Welcome to the e-CCO Library Archive!

Filter:
P234. The effect of allopurinol on thiopurine metabolite concentrations in patients with inflammatory bowel disease
P234. Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers
P234

Development of a patient reported disease activity score to screen for mucosal inflammation in inflammatory bowel disease.

Authors:

M. de Jong*1, J. Degens1, T. van den Heuvel1, M. Romberg-Camps2, B. Winkens3, T. Markus4, A. Masclee1, A. van Tubergen5, D. Jonkers1, M. Pierik1

1MUMC, division Gastroenterology-Hepatology, Maastricht, Netherlands, 2ORBIS Medical Centre, Gastroenterology and Hepatology, Sittard, Netherlands, 3Maastricht University, Department of Methodology and Statistics, Maastricht, Netherlands, 4CCUVN, CCUVN, Woerden, Netherlands, 5MUMC, division Rheumatology, Maastricht, Netherlands

P235.

Does liver transplantation affect the risk for colorectal neoplasia in PSC-IBD patients?

Authors:

J. Maljaars, K. Sebib Korkmaz, A. Van der Meulen, B. van Hoek, Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, Netherlands

P235. Clinical value of measuring trough levels and human anti-chimeric antibodies in patients with inflammatory bowel disease who lost response to infliximab therapy
P235. Frequency of Clostridium difficile infection in gastroenterology department
Authors:

E. Belousova1, E. Volchkova1, E. Rusanova2, M. Podlesskikh1, O. Tsodikova1, 1Moscow Regional Research Clinical Institute, Gastroenerology, Moscow, Russian Federation, 2Moscow Regional Research Clinical Institute, Laboratory, Moscow, Russian Federation

P235. Long-term clinical experience with vedolizumab (VDZ) in patients with mild to moderate ulcerative colitis (UC)
P235

Clinical utility of the Lémann index and Rutgeerts score to predict postoperative course of Crohn's disease: a retrospective single-center cohort study.

Authors:

G. Fiorino*1, C. Bonifacio2, M. Allocca1, M. Alfieri1, M. Sacchi3, I. Bravatà4, D. Gilardi1, P. Turri1, M. Delliponti1, A. Spinelli3, L. Balzarini2, A. Repici4, L. Peyrin-Biroulet5, S. Danese1

1Humanitas Research Hospital, IBD Center, Gastroenterology, Rozzano, Milan, Italy, 2Humanitas Research Hospital, Radiology, Rozzano, Milan, Italy, 3Humanitas Research Hospital, IBD Surgery, Colo-rectal Surgery, Rozzano, Milan, Italy, 4Humanitas Research Hospital, Endoscopy Unit, Gastroenterology, Rozzano, Milan, Italy, 5Nancy University Hospital, Université de Lorraine, Gastroenterology and Hepatology, Vandoeuvre-les-Nancy, France

P236.

Disease severity after 3 years of treating newly diagnosed pediatric Crohn's disease patients (the BELCRO cohort)

Authors:

E. De Greef1, J.M. Mahachie John2, I. Hoffman3, F. Smets4, S. Van Biervliet5, P. Bontems6, I. Paquot7, P. Alliet8, K. Van Steen2, G. Veereman1, 1UZ Brussel, Pediatric Gastroenterology, Jette, Belgium, 2Montefiori Institute, Systems and Modelling Unit, Liege, Belgium, 3UZ Gasthuisberg, Pediatric Gastroenterology, Leuven, Belgium, 4UCL St Luc, Pediatric Gastroenterology, Brussels, Belgium, 5UZ Gent, Pediatric Gastroenterology, Gent, Belgium, 6HUDERF, Pediatric Gastroenterology, Brussels, Belgium, 7CHC de l'espérance, Pediatric Gastroenterology, Liège, Belgium, 8Jessa Hospital, Pediatric Gastroenterology, Hasselt, Belgium

P236. Fecal calprotectin as a surrogate marker of acute microscopic inflammation in ulcerative colitis patients with endoscopic remission
Authors:

T. Lobaton Ortega1, E. Dueñas1, A. Lopez-Garcia1, F. Rodriguez-Moranta1, L. Carolina2, X. San Juan2, L. Rodriguez1, A. Ruiz1, J. Guardiola1, 1Hospital Universitari Bellvitage, Gastroenterology, Barcelona, Spain, 2Hospital Universitari Bellvitage, Pathology, Barcelona, Spain

P236. High intake of fermentable carbohydrates and food sugars associated with increased disease activity in inflammatory bowel disease
P236. The requirements of adolescents with inflammatory bowel disease for successful transition: Differing perceptions from a survey of adult and paediatric gastroenterologists
P236

Placebo response and remission rates in Ulcerative Colitis clinical trials: Systematic review and meta-analysis

Authors:

V. Jairath*1, C. Parker2, G. Zou2, 3, J.K. MacDonald2, T. Alameel4, M. Albeshir4, M. Almadi5, T. Altaweel6, N. Atkinson1, S. Biswas1, T. Chapman1, P.S. Dulai7, M. Glaire8, D. Hoekman9, A. Koutsoumpas1, E. Minas10, M.H. Mosli2, 11, M.A. Samaan2, 9, M.K. Vandervoort2, S.P. Travis12, G. D'Haens2, 9, B.G. Levesque2, 7, W.J. Sandborn2, 7, B.G. Feagan2, 3, 13

1Oxford University Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom, 2Robarts Clinical Trials Inc., Robarts Research Institute, University of Western Ontario, London, Ontario, Canada, 3University of Western Ontario, Department of Epidemiology and Biostatistics, London Ontario, Canada, 4King Fahad Specialist Hospital-Dammam, Department of Medicine, Dammam, Saudi Arabia, 5King Khalid University Hospital, Division of Gastroenterology, Riyadh, Saudi Arabia, 6Mubarak Al-Kabeer Hospital, Division of Gastroenterology, Jabriyah, Kuwait, 7University of California San Diego, Division of Gastroenterology, La Jolla, United States, 8John Radcliffe Hospital, Department of Gastroenterology, Oxford, United Kingdom, 9University of Amsterdam, Academic Medical Center, Amsterdam, Netherlands, 10Wexham Park Hospital, Department of Gastroenterology, Slough, United Kingdom, 11King Abdulaziz University, Department of Medicine, Jeddah, Saudi Arabia, 12John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom, 13University of Western Ontario, Department of Medicine, London , Canada

P237.

Differential diagnosis between intestinal tuberculosis and Crohn's disease – A prospective multicenter study from China

Authors:

Y. He1, Z. Zhu2, Y. Chen3, W. Liao2, C. Ouyang4, M. Huang5, R. Hu6, Y. Yang7, J. Qian7, Q. Ouyang6, X. Wu4, B. Xia5, N. Lv2, M. Chen1, P. Hu1, 1The First Affiliated Hospital of SunYat-Sen University, Gastroenterology, Guangzhou, China, 2The First Affiliated Hospital of Nanchang University, Gastroenterology, Nanchang, China, 3The First Affiliated Hospital of SunYat-Sen University, Medical Ultrasonics, Guangzhou, China, 4The Second Xiangya Hospital of Central South University, Gastroenterology, Changsha, China, 5Zhongnan Hospital of Wuhan University, Gastroenterology, Wuhan, China, 6West China Hospital, Sichuan University, Gastroenterology, Sichuan, China, 7Peking Union Medical College Hospital, Gastroenterology, Beijing, China

P237. Correlation between fecal calprotectin levels and clinical activity in ulcerative colitis in a phase I study with an anti-MAdCAM‑1 monoclonal antibody
P237. Feasibility and safety of granulocytapheresis in Crohn's disease: A prospective cohort study
P237. Features of the Japanese clinical practice guidelines for Crohn's disease with reference to those in the western world
Authors:

K. Matsuoka1, F. Ueno2, T. Matsui3, M. Watanabe4, T. Hibi1, 1Keio University School of Medicine, Gastroenterology and Hepatology, Tokyo, Japan, 2Ofuna Chuo Hospital, Kanagawa, Japan, 3Fukuoka University Chikushi Hospital, Gastroenterology, Fukuoka, Japan, 4Tokyo Medical and Dental University, Gastroenterology and Hepatology, Tokyo, Japan

P237

Accuracy of a rapid fecal calprotectin test as a predictor of mucosal healing in patients with Ulcerative Colitis (UC)

Authors:

R. Ferreiro*, M. Barreiro-de Acosta, N. Vallejo, D. De la Iglesia, L. Urisarri, I. Baston, A. Lorenzo, J.E. Dominguez-Munoz

University Hospital Santiago de Compostela, Gastroenterology, Santiago, Spain

P238.

Diagnostic value of serum adenosine deaminase levels in patients with inflammatory bowel diseases

Authors:

C. Gonen1, Y. Gokden1, A. Salturk1, K. Kochan1, S. Ozkara2, 1Haydarpasa Numune Training and Research Hospital, Department of Gastroenterology, Istanbul, Turkey, 2Haydarpasa Numune Training and Research Hospital, Department of Pathology, Istanbul, Turkey

P238. Feasibility of the second-generation colon capsule endoscopy in patients with ulcerative colitis with a reduced preparation regimen
Authors:

T. Kobayashi1,2,3, N. Hosoe2, K. Matsuoka3, M. Naganuma2, M. Nakano1, Y. Ishibashi3, K. Kimura3, K. Yoneno3, S. Usui3, K. Kashiwagi2, T. Hisamatsu3, N. Inoue2, H. Serizawa1, N. Watanabe1, T. Kanai3, H. Imaeda4, T. Hibi3, H. Ogata2, 1Kitasato University Kitasato Institute Hospital, Inflammatory Bowel Disease Center, Tokyo, Japan, 2Keio University, Center for Diagnostic and Therapeutic Endoscopy, Tokyo, Japan, 3Keio University, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokyo, Japan, 4Department of General Internal Medicine, Saitama Medical University, Saitama, Japan